Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus
- PMID: 9777321
- DOI: 10.1046/j.1365-2362.1998.0280s2008.x
Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus
Abstract
The World Health Organization distinguishes among non-diabetic persons a form of glucose intolerance defined as impaired glucose tolerance (IGT). The main reason for considering IGT as a diagnostic entity is its prognostic value for the development of non-insulin-dependent diabetes mellitus (NIDDM). However, the use of one or two oral glucose tolerance tests (OGTT) for the definition of IGT and the large variability of the 2-h glucose level may explain the wide range of the incidence rates reported for NIDDM in subjects with IGT. It is evident that the pathogenesis of diabetes is still poorly understood. Both insulin resistance and impaired function of the beta-cell are thought to be important contributing factors in the development of diabetes. The 2-h post-load glucose level from the OGTT is most powerful for the prediction of the development of NIDDM. In addition, a fasting hyperinsulinaemia and a low glucose removal rate, both reflecting insulin resistance, were found to be associated with a higher risk for the progression of NIDDM. In the San Antonio Study and in the Hoorn Study high fasting proinsulin levels, reflecting beta-cell dysfunction, were associated with progression to NIDDM. Lipid levels did not predict progression to NIDDM in most studies. A two-step model for the development of NIDDM is hypothesized. The first step, the transition from normal to impaired glucose tolerance, is assumed to depend mainly on the presence of insulin resistance. The second step, progressing from IGT to diabetes, although accompanied by some further worsening of insulin resistance, is thought to be primarily dependent on the development of beta-cell dysfunction.
Similar articles
-
Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study.Diabetologia. 1996 Jan;39(1):113-8. doi: 10.1007/BF00400421. Diabetologia. 1996. PMID: 8720611
-
Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.Diabetes Care. 1997 Jul;20(7):1101-7. doi: 10.2337/diacare.20.7.1101. Diabetes Care. 1997. PMID: 9203444
-
In vivo beta-cell function at the transition to early non-insulin-dependent diabetes mellitus.Metabolism. 1995 Jun;44(6):757-64. doi: 10.1016/0026-0495(95)90189-2. Metabolism. 1995. PMID: 7783660
-
Hyperinsulinaemia is a predictor of non-insulin-dependent diabetes mellitus.Diabete Metab. 1991 May;17(1 Pt 2):101-8. Diabete Metab. 1991. PMID: 1936464 Review.
-
Toward an integrated phenotype in pre-NIDDM.Diabet Med. 1996 Sep;13(9 Suppl 6):S67-77. Diabet Med. 1996. PMID: 8894486 Review.
Cited by
-
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant.J Endocrinol Invest. 2006 Apr;29(4):330-6. doi: 10.1007/BF03344104. J Endocrinol Invest. 2006. PMID: 16699299
-
CDKAL1-related single nucleotide polymorphisms are associated with insulin resistance in a cross-sectional cohort of Greek children.PLoS One. 2014 Apr 2;9(4):e93193. doi: 10.1371/journal.pone.0093193. eCollection 2014. PLoS One. 2014. PMID: 24695378 Free PMC article. Clinical Trial.
-
The effect of α- or β-casein addition to waxy maize starch on postprandial levels of glucose, insulin, and incretin hormones in pigs as a model for humans.Food Nutr Res. 2012;56. doi: 10.3402/fnr.v56i0.7989. Epub 2012 Apr 13. Food Nutr Res. 2012. PMID: 22509144 Free PMC article.
-
Mechanical Signals As a Non-Invasive Means to Influence Mesenchymal Stem Cell Fate, Promoting Bone and Suppressing the Fat Phenotype.Bonekey Osteovision. 2009 Apr 1;6(4):132-149. doi: 10.1138/20090371. Bonekey Osteovision. 2009. PMID: 22241295 Free PMC article.
-
Changes in Weight and Glucose Can Protect Against Progression in Early Diabetes Independent of Improvements in β-Cell Function.J Clin Endocrinol Metab. 2016 Nov;101(11):4076-4084. doi: 10.1210/jc.2016-2056. Epub 2016 Aug 17. J Clin Endocrinol Metab. 2016. PMID: 27533307 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical